Perioperative stroke, encephalopathy, and central nervous system dysfunction

Journal of Intensive Care Medicine

Volumn 12, Issue 3, 1997, Pages 148-160

  Mangano, Dennis T ^b   Mangano, Christina Mora ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b McSPI Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM CHANNEL BLOCKING AGENT; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; SCAVENGER;

AORTA ATHEROSCLEROSIS; ARTICLE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DOPPLER ECHOGRAPHY; HEART SURGERY; HEMODYNAMIC MONITORING; HUMAN; MORBIDITY; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0031000277     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669701200305     Document Type: Article

References (76)

1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-184
2. World Health Organization. Global estimates for health situation assessment and projections. Division of Epidemiological Surveillance and Health Situation and Trend Assessment. Geneva: 1990:V:51
3. Frye RL, Higgins MW, Beller GA, et al. Task force III: major demographic and epidemiologic trends affecting adult cardiology, J Am Coll Cardiol 1988;12:840-846
4. Mangano DT. Perioperative cardiac morbidity-epidemiology, costs, problems, and solutions. West J Med 1994;161:87-89
5. Mangano DT. Cardiovascular morbidity and CABG surgery - a perspective: epidemiology, costs, and potential therapeutic solutions. J Cardiac Surg 1995;10:366-368
6. Mangano DT, Goldman L. Preoperative assessment of the patient with known or suspected coronary disease. N Engl J Med 1995;333:1750-1756
7. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990;323:1781-1788
8. Roach GW, Kanchuger M, Mora Mangano CT, et al. Adverse cerebral outcomes following coronary bypass surgery, N Fngl J Med 1996;335:1857-1863
9. Mangano DT, for the McSPI Research Group. Effects of acadesine on myocardial infarction, stroke and death following surgery: a meta-analysis of the five international randombed trials. JAMA 1997;277:325-332
10. Mora CT, Murkin JM. The central nervous system: responses to cardiopulmonary bypass. In: Mora CT, ed. Cardiopulmonary bypass: principles and techniques of extracorporeal circulation. New York, NY: Springer-Verlag, 1995:114-146
11. Sotaniemi KA, Juolasmas A, Hokkanen ET. Neuropsychologic outcome after open-heart surgery, Arch Neurol 1981;38:2-8
12. Savageau JA, Stanton B, Jenkins CD, Klein MD. Neuropsychological dysfunction following elective cardiac operation. I. Early assessment, J Thorac Cardiovasc Surg 1982;84: 585-594
13. Savageau JA, Stanton B, Jenkins CD, Frater WM, Neuropsychological dysfunction following elective cardiac operation. II, A six-month reassessment. J Thorac Cardiovasc Surg 1982;84:595-600
14. Shaw PJ, Bates D, Cartlidge NEF, et al, Early intellectual dysfunction following coronary bypass surgery. Q J Med 1986;58:59-68
15. Newman S, Smith P, Treasure T, Joseph P. Acute neuropsychological consequences of coronary artery bypass surgery. Curr Psychol Res Rev 1987;6:115-124
16. Mattlar CE, Knuts LR, Engblom E, Vanttinen E. Neuropsychological findings and personality structural asociated with coronary artery bypass surgery (CABG): an eight month follow-up study. In: Willner A, Rodewald G, eds. Impact of cardiac surgery on the quality of life: neurological and psychological aspects, New York, NY: Plenum Press, 1990:211-219
17. Nevin M, Adams S, Colchester ACF, Pepper JR. Evidence for involvement of hypocapnia and hypoperfusion in etiology of neurological deficit after cardiopulmonary bypass. Lancet 1987;2:1493-1495
18. Newman S, Klinger L, Venn G, et al. The persistence of neuropsychological deficits twelve months after coronary artery bypass surgery, In: Rodewald W, ed. Impart of cardiac surgery on the quality of life. New York, NY: Plenum Press, 1990:173-179
19. Martzke JS, Murkin JM, Buchan AM, et al. A prospective survey of cognitive function following coronary artery bypass (CAB), J Clin Exp Neuropsychiatry 1992;14:A60
20. Smith PCC, Treasure T, Newman SP, et al. Cerebral consequences of cardiopulmonary bypass. Lancet 1986;1:823-825
21. Hammeke TA, Hastings JE. Neurpsychologic alterations after cardiac operation, J Thorac Cardiovasc Surg 1988;96: 326-331
22. Raymond M, Conklin C, Schaeffer J, et al. Coping with transient intellectual dysfunction after coronary bypass surgery, Heart Lung 1984;13:531-539
23. Shaw PJ, Bates D, Cartilidge NEF, et al. Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987;18:700-707
24. Smith PL. The cerebral complications of coronary artery bypass surgery. Ann R Coll Surg Engl 1988;70:212-216
25. Murkin JM, Martzke JS, Buchan AM, Bentley C, pH management during prolonged hypothermic cardiopulmonary bypass significantly influences the incidence of postoperative neuropsychological dysfunction. Can J Anaesth 1993;40:A46
26. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238-248
27. Mangano DT, for the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Acadesine and perioperative myocardial infarction: results of the third multicenter trial, J Thorac Cardiovasc Surg 1996 (in press)
28. Gold JP, Charlson ME, Wllllams-Russo P, et al. Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995;110:1302-1314
29. Pugsley W, Klinger L, Paschalis C, et al. Microemboli and cerebral impairment during cardiac surgery. Vase Surg 1990;24:34-43
30. Moody DM, Bell MA, Challa VR, et al. Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990;28:477-486
31. Marschall K, Kanchuger M, Kessler K, et al. Superiority of transesophageal echocardiography in detecting aortic arch atheromatous disease: identification of of patients at increased risk of stroke during cardiac surgery. J Cardiothorac Vasc Anesth 1994;8:5-13
32. Jones EF, Kalman JM, Calafiore P, et al. Proximal aortic atheroma, Stroke 1995;26:218-224
33. Wareing TH, Davila-Roman VG, Barzilai B, et al. Management of the severely atherosclerotic ascending aorta during cardiac operations: a strategy for detection and treatment. J Thorac Cardiovasc Surg 1992;103:453-462
34. Dávila-Roman VG, Barzilai B, Wareing TH, et al. Atherosclerosis of the ascending aorta: prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke 1994;25:2010-2016
35. Padayachee TS, Parsons S, Theobold R, et al. The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial Doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg 1987;44:298-302
36. Chopp M, Welch KMA, Tidlwell CD, et al. Effect of mild hyperthermia on recovery of metabolic function after global cerebral ischemia in cats. Stroke 1988;19:1521-1525
37. Dietrich WD, Busto R, Valdes I, Loor Y. Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 1990;21:1318-1325
38. Mora CT, Henson MB, Weintraub WS, et al. The effect of temperature management during cardiopulmonary bypass on neurological and neuropsychological outcomes in coronary revascularization patients. J Thorac Cardiovasc Surg 1996;112:5l4-522
39. Martin TC, Graver JM, Gott JP, et al. Prospective, randomized trial of retrograde warm-blood cardioplegia: myocardial benefit and neurologic threat. Ann Thorac Surg 1994;57: 298-304
40. Newman MF, Wolman R, Marschall K, el al. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass grafting. Circulation 1996;94:11274-11280
41. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Epidemiology II. The Study Design and Protocol, 1996 (on file at the Ischemia Research and Education Foundation) San Francisco, CA
42. Fields WS, Maslenikov V, Meyer JS, et al. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA 1970;211:1993-2003
43. Shaw DA, Venables GS, Cartlidge NEF, et al. Carotid endarter-ectomy in patients with transient cerebral ischaemia. J Neurol Sci 1984;64:45-53
44. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453
45. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial. Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243
46. Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991;266:3289-3294
47. The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stensosis. Stroke 1991;22:1229-1235
48. Mayo Asymptomatic Carotid Endarterectomy Study Group. Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 1992;67:513-518
49. Hobson RW II, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993;328:221-227
50. Newman DC, Hicks RG, Combined carotid and coronary artery surgery: a review of the literature. Ann Thorac Surg 1988;45:574-581
51. Scheller MS, Tateishi A, Drummond JC, Zornow MH. The effects of sevoflurane on cerebral blood-flow, cerebral metabolic rate for oxygen, intracranial pressure, and the electroencephalogram are similar to those of isoflurane in the rabbit. Anesthesiology 1988;68:548-551
52. Van Hemelrijck J, Fitch W, Mattheussen M, et al. Effect of propofol on cerebral circulation and autoregulation in the baboon. Anesth Analg 1990;71:49-54
53. Miyazaki M, Nazarali AJ, Boisvert DP, et al. Inhibition of ischemia-induced brain catecholamine alterations by clonidine, Brain Res Bull 1989;22:207-211
54. Koide T, Wieloch TW, Siesjö BK. Circulating catccholamines modulate ischemic brain damage. J Cereb Blood Flow Metab 1986;6:559-565
55. Huffman WE, Kochs E, Werner C, et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Anesthesiology 1991;75:328-332
56. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic - ischemic brain damage. Ann Neurol 1986;19: 105-111
57. Zivin JA, Choi DW. Stroke therapy. Sci Am 1991;July:56-63
58. Davis JN, Alberts MJ, Goldstein LB. Cerebrovascular diseases. Nineteenth Princeton Conference. Boston, MA, Stroke, March 1995
59. Zivin JA. Thrombolytic therapy for stroke. In: Weinstein P, Faden A, eds. Protection of the brain from ischemia. Philadelphia: Williams & Wilkins, 1990;3:231-236
60. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions, J Neurosci 1990;10:2493-2501
61. Fagg GE, Foster AC. Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 1983;9:701-719
62. Benveniste H, Jorgensen MB, Sandberg M, et al. Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J Cereb Blood Flow Metab 1989;9:629-639
63. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987;7:357-368
64. Coyle JT, Bird SJ, Evans RH, et al. Excitatory amino-acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci Res Prog Bull 1981;19:l-427
65. Churn SB, Taft WC, DeLorenzo RJ. Effects of ischemia on multifunctional calcium/calmodulin-depependcnt protein kinase type II in the gerbil. Stroke 1990;21:111-112
66. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
67. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke, N Engl J Med 1996;335:145-150
68. Leung JL, Stanley T, Mathew J, et al. Initial multicenter randomized controlled trial on the safety and efficacy of acadesine in patients undergoing CABG surgery. Anesth Analg 1994;78:420-434
69. The Multicenter Study of Perioperative Ischemia (McSPI) Group Research. Effects of acadesine on morbidity and mortality following coronary artery bypass graft surgery. Anesthesiology 1995;83:658-673
70. Menasché P. Multinational study of the effect of acadesine on myocardial infarction and adverse cardiovascular outcomes associated with CABG surgery. Eur Heart J 1993;14 (suppl):425
71. Menasché P, Jamieson W, Flameng W, et al. Acadesine: assessment of the effect on morbidity and mortality when used in association with coronary artery revascularization. J Thorac Cardiovasc Surg 1995;110:1096-1106
72. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia, Circulation 1992;85:893-904
73. Gruber HE, Hoffer ME, McAlllster DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury. Circulation 1989;80:1400-1411
74. Henry C, Young M, Zhang C, et al. Adenosine release from red cells mediates inhibition of platelet aggregation by acadesine and delays post-thrombolytic reoceluslon in dogs, Circ Suppl 1991;84:247
75. Hoffmeister H, Mauser M, Schaper W. Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium. Basic Res Cardiol 1985;80:445-458
76. Ambrosio G, Jacobus W, Mitchell M, et al. Effects of ATP precursors on ATP and free ADP content and functional recovery of postischemic hearts. Am J Physiol 1989;256: H560-H566